Tags |
|
|
Links |
|
|
E-Folder - New Requirement for NSAs - Background Check
More and more, we, as a nation, are becoming ultra-concerned and extremely protective of personal data and personal information. Identity theft, depending on w
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ho you believe, is either running rampant in our country or not as prevalent as we have been led to believe. Still the “powers that be“ appear to be pushing fo
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
r getting a handle on verifying the identity of all Notary Signing Agents. Some will see this as progress, while others tend to view it as a continuation of th
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
Big Brother Syndrome.
In any event, for those who haven’t been updated, here’s what is transpiring now. Some lending institutions, banks, title companies and
In any event, for those who haven’t been updated, here’s what is transpiring now. Some lending institutions, banks, title companies and
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
signing agencies are requesting that some of their “employees’ and “service personnel“ involved in the lending process undergo background screening and complia
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
nce training. Pretty much any individual that has access to the financial information of borrowers must submit to a background check. The “kicker“ here is that
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
they also have to pay for it - more on that later! Notary Signing Agents fall right in the middle of that group. This sudden requirement is based on their loo
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
se interpretation of Gramm-Leach Bliley Financial Services Modernization Act.
While the members of CD&C Business & Legal Form Processing Services, LLC (“CD&C”)
While the members of CD&C Business & Legal Form Processing Services, LLC (“CD&C”)
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
have yet to be required to provide certification, there have been such requests of some of our subcribers from various lending agencies and signing companies.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
However quite a few questions are emerging as to the sudden rush to have the certification done and as to whether it is necessary to do it. Also, the cost of d
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
oing this certification ranges anywhere from $9 to $150. Based on our readings, the general consensus is that there needs to be a definitive ruling on whether
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
or not the requirement was supposed to be applied to “contractors“ such as NSAs.
When is it going to be a requirement for signing companies/title, escrow and v
When is it going to be a requirement for signing companies/title, escrow and v
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
rious lenders to submit to background checks as required of the NSA to help prevent fraud? Maybe, if there was a requirement, it would reduce non-payment to s
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
igning agents. It would be harder for a “Mr. Joe” to open shop for a few days, close shop and re-open under a different name; all the while refusing to pay NSA
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
s. There should be a list/system where reputable companies are listed to help the NSA weed out the bad companies. The NSA will be put on a list/system where th
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
title companies will only hire the NSA who have had the background check and are certified. No system is perfect, but it can help to reduce the NSA’s risks.
W
W
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
hy do NSAs have to pay for the background check? The title companies are requiring the background check, so why shouldn’t they pay for it? Can the NSA purchas
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
e the background check without certification? Are they willing to pay an increased fee for advance education now that we are certified? Another expense added
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
nd we are still being underpaid or not paid at all…
Until that can be established, we recommend that you think long and hard about forking over your money. An
Until that can be established, we recommend that you think long and hard about forking over your money. An
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
d if it turns out that we actually do need to have our certification, then we should discuss all options so as to have the most cost efficient service available
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/581/e-folder-New-Requirement-for-NSAs--Background-Check.html">New Requirement for NSAs - Background Check</a>
BB link (for phorums):
[url=http://www.e-folder.org.ua/article/581/e-folder-New-Requirement-for-NSAs--Background-Check.html]New Requirement for NSAs - Background Check[/url]
Related Articles:
Choose Ideal Construction Cost Estimating Software For Your Company
Bookmark it:
|